Skip to main content
SpringerLink
Log in

Sinapultide surfactant reduces hospital costs in premature infants

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Discovery Laboratories Inc.Discovery Labs Presents Pharmacoeconomic Data Linking Decreased Hospital Costs to Reduction in Reintubation Following Surfaxin Use. Media Release: 20 Apr 2009. Available from: URL: http://www.discoverylabs.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sinapultide surfactant reduces hospital costs in premature infants. Pharmacoecon. Outcomes News 578, 4 (2009). https://doi.org/10.2165/00151234-200905780-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905780-00008

Keywords

Search

Navigation